scispace - formally typeset
S

Somnath Singha Roy

Researcher at Chittaranjan National Cancer Institute

Publications -  21
Citations -  634

Somnath Singha Roy is an academic researcher from Chittaranjan National Cancer Institute. The author has contributed to research in topics: Oxidative stress & Lipid peroxidation. The author has an hindex of 14, co-authored 21 publications receiving 527 citations. Previous affiliations of Somnath Singha Roy include Sanjay Gandhi Post Graduate Institute of Medical Sciences.

Papers
More filters
Journal ArticleDOI

Unveiling the groove binding mechanism of a biocompatible naphthalimide-based organoselenocyanate with calf thymus DNA: an "ex vivo" fluorescence imaging application appended by biophysical experiments and molecular docking simulations

TL;DR: Experimental results based on spectroscopy, isothermal calorimetry, electrochemistry aided with DNA-melting, and circular dichroism studies unambiguously established the formation of a groove binding network between the NPOS and ctDNA.
Journal ArticleDOI

Tunable solvatochromic response of newly synthesized antioxidative naphthalimide derivatives: intramolecular charge transfer associated with hydrogen bonding effect.

TL;DR: The solvatochromic behavior of two newly synthesized naphthalimide derivatives (I and II) which have potential antioxidative activities in anticarcinogenic drug development treatment, has been monitored in protic and aprotic solvents of different polarity applying steady-state and time-resolved fluorescence techniques.
Journal ArticleDOI

Naphthalimide based novel organoselenocyanates: finding less toxic forms of selenium that would retain protective efficacy.

TL;DR: A series of naphthalimide based organoselenocyanates were synthesized and screened for their toxicity as well as their ability to modulate several detoxifying/antioxidative enzyme levels at a primary screening dose of 3 mg/kg b.w. in normal Swiss albino mice for 30 days.
Journal ArticleDOI

Attenuation of doxorubicin-induced cardiotoxicity and genotoxicity by an indole-based natural compound 3,3'-diindolylmethane (DIM) through activation of Nrf2/ARE signaling pathways and inhibiting apoptosis.

TL;DR: It is suggested that DIM has promising chemoprotective efficacy against DOX-induced toxicity and indicates its future use as an adjuvant in chemotherapy.